Passage of Magnetic Tat-Conjugated Fe(3)O(4)@SiO(2) Nanoparticles Across In Vitro Blood-Brain Barrier

Delivery of diagnostic or therapeutic agents across the blood-brain barrier (BBB) remains a major challenge of brain disease treatment. Magnetic nanoparticles are actively being developed as drug carriers due to magnetic targeting and subsequently reduced off-target effects. In this paper, we developed a magnetic SiO(2)@Fe(3)O(4) nanoparticle-based carrier bound to cell-penetrating peptide Tat (SiO(2)@Fe(3)O(4) (-Tat)) and studied its fates in accessing BBB. SiO(2)@Fe(3)O(4)-Tat nanoparticles (NPs) exhibited suitable magnetism and good biocompatibility. NPs adding to the apical chamber of in vitro BBB model were found in the U251 glioma cells co-cultured at the bottom of the Transwell, indicating that particles passed through the barrier and taken up by glioma cells. Moreover, the synergistic effects of Tat and magnetic field could promote the efficient cellular internalization and the permeability across the barrier. Besides, functionalization with Tat peptide allowed particles to locate into the nucleus of U251 cells than the non-conjugated NPs. These results suggest that SiO(2)@Fe(3)O(4)-Tat NPs could penetrate the BBB through the transcytosis of brain endothelial cells and magnetically mediated dragging. Therefore, SiO(2)@Fe(3)O(4)-Tat NPs could be exploited as a potential drug delivery system for chemotherapy and gene therapy of brain disease.